TGFB1 and juvenile idiopathic arthritis: The results of TGF-β1 concentrations in the blood of patients with JIA treated with etanercept indicate that ETA, besides leading to remission of the disease, simultaneously decreases the concentration of the assessed factor and, thus, returns TGF-β1-dependent homeostasis of chondrocytes and cartilaginous ECM.